Full-Time

QC Specialist

Updated on 1/29/2025

Arcellx

Arcellx

51-200 employees

Develops immunotherapies for cell therapy

Biotechnology
Healthcare

Compensation Overview

$90k - $110kAnnually

+ Bonus + Equity Grant

Mid, Senior

San Carlos, CA, USA

Relocation assistance is offered if required.

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech

You match the following Arcellx's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • BS or MS in biological sciences or a related field.
  • 3+ years of pharmaceutical or biotechnology industry experience.
  • Previous experience performing environmental monitoring, PCR and/or Flow Cytometry based assays is preferred.
  • Excellent written and oral communication skills.
Responsibilities
  • Execute release testing for cell therapy products and in-process samples using flow cytometry, PCR, ELISA, sterility, mycoplasma, and endotoxin methods.
  • Perform routine cleanroom environmental monitoring.
  • Contribute to drafting SOPs, forms, and logbooks governing the upkeep, calibration, and preventive maintenance of lab equipment and instruments.
  • Coordinate maintenance activities for equipment and instruments with internal resources and external partners.
  • Manage inventory of lab supplies and materials.
  • Design and maintain the organization of the laboratory.
  • Support GMP investigations, out of specification test results, invalid assays, deviations, change controls, and CAPAs.
Desired Qualifications
  • Previous experience performing environmental monitoring, PCR and/or Flow Cytometry based assays is preferred.

Arcellx develops immunotherapies aimed at improving cell therapy for serious diseases. Their products focus on advanced techniques that harness the body's immune system to fight illnesses. The company collaborates with healthcare providers and research institutions to create and test these therapies, generating revenue through partnerships and licensing agreements. What sets Arcellx apart from competitors is its commitment to addressing unmet medical needs with proprietary treatments that prioritize safety and effectiveness. The ultimate goal is to provide innovative solutions that enhance patient care and outcomes.

Company Stage

IPO

Total Funding

$194.5M

Headquarters

Gaithersburg, Maryland

Founded

2014

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Growing investment in personalized medicine aligns with Arcellx's tailored immunotherapies.
  • Advancements in gene editing like CRISPR enhance precision in engineered cell therapies.
  • Outpatient CAR-T administration could reduce costs and increase accessibility for Arcellx.

What critics are saying

  • Competition from established CAR-T therapies like Abecma and Carvykti could limit market share.
  • Dependency on Gilead's Kite partnership poses risks if partnership dynamics change.
  • Phase 3 iMMagine-3 trial delays or failures could impact anito-cel's market timeline.

What makes Arcellx unique

  • Arcellx's CART-ddBCMA has FDA Fast Track and Orphan Drug designations.
  • The novel D-Domain binder in anito-cel enhances antigen binding and cell killing.
  • ARC-SparX offers dosable and controllable CAR-T therapy options.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Unlimited Paid Time Off

Flexible Work Hours

401(k) Company Match

Fully-Paid Parental Leave

Tuition Reimbursement

Relocation Assistance